search
Back to results

Incidence of Delirium in Hip Fracture Patients Randomized to Regular Hypnotics vs Placebo

Primary Purpose

Hip Fracture, Delirium

Status
Terminated
Phase
Phase 4
Locations
Denmark
Study Type
Interventional
Intervention
Zolpidem
Sponsored by
Hvidovre University Hospital
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional prevention trial for Hip Fracture focused on measuring Hip fracture, delirium, sleep disturbance, hypnotic

Eligibility Criteria

70 Years - undefined (Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Primary hip fracture, no substance abuse, no regular opioid, corticosteroid or benzodiazepine therapy, hepatic insufficiency, myastenia gravis, allergies to drug components Exclusion Criteria: Severe respiratory insufficiency

Sites / Locations

  • Hvidovre University Hospital

Outcomes

Primary Outcome Measures

Incidence and severity of postoperative delirium

Secondary Outcome Measures

Sleep quality
mobilization
loss of functional ability
length of stay
sedation
nocturnal nursing events

Full Information

First Posted
February 3, 2006
Last Updated
August 29, 2011
Sponsor
Hvidovre University Hospital
Collaborators
IMK Fonden
search

1. Study Identification

Unique Protocol Identification Number
NCT00286936
Brief Title
Incidence of Delirium in Hip Fracture Patients Randomized to Regular Hypnotics vs Placebo
Official Title
Incidence of Delirium in Hip Fracture Patients Randomized to Regular Hypnotics vs Placebo
Study Type
Interventional

2. Study Status

Record Verification Date
September 2006
Overall Recruitment Status
Terminated
Why Stopped
Slow inclusion resulting in premature termination due to logistics
Study Start Date
February 2004 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
January 2007 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Hvidovre University Hospital
Collaborators
IMK Fonden

4. Oversight

5. Study Description

Brief Summary
To examine the influence of regular hypnotic therapy on the incidence of delirium after hip fracture surgery
Detailed Description
Delirium is prevalent after hip fracture surgery. Delirium has been linked to postoperative sleep disturbances. Zolpidem is a non-benzodiazepine hypnotic that preserves REM sleep. The present study investigates the incidence of delirium in hip fracture patients randomized to Zolpidem treatment 5 mg vs placebo in the perioperative phase.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hip Fracture, Delirium
Keywords
Hip fracture, delirium, sleep disturbance, hypnotic

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Double
Allocation
Randomized
Enrollment
96 (Anticipated)

8. Arms, Groups, and Interventions

Intervention Type
Drug
Intervention Name(s)
Zolpidem
Primary Outcome Measure Information:
Title
Incidence and severity of postoperative delirium
Secondary Outcome Measure Information:
Title
Sleep quality
Title
mobilization
Title
loss of functional ability
Title
length of stay
Title
sedation
Title
nocturnal nursing events

10. Eligibility

Sex
All
Minimum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Primary hip fracture, no substance abuse, no regular opioid, corticosteroid or benzodiazepine therapy, hepatic insufficiency, myastenia gravis, allergies to drug components Exclusion Criteria: Severe respiratory insufficiency
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nicolai B Foss, MD
Organizational Affiliation
Hvidovre University Hospital
Official's Role
Study Director
Facility Information:
Facility Name
Hvidovre University Hospital
City
Hvidovre
ZIP/Postal Code
2650
Country
Denmark

12. IPD Sharing Statement

Learn more about this trial

Incidence of Delirium in Hip Fracture Patients Randomized to Regular Hypnotics vs Placebo

We'll reach out to this number within 24 hrs